#KO
### π’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ν¨λ¥ λ° ν¨κ³Ό
* μ΄ μ•½μ€ κ³„μ μ„± λ° λ‹¤λ…„μ„± μ•λ λ¥΄κΈ°μ„± λΉ„μ—Ό(μ½”μ—Ό), μ•λ λ¥΄κΈ°μ„± κ²°λ§‰μ—Ό, λ§μ„± νΉλ°μ„±(μ›μΈ λ¶λ…μ) λ‘λ“λ¬κΈ°, ν”Όλ¶€κ°€λ ¤μ›€μ¦, μµμ§„, ν”Όλ¶€μ—Ό(ν•μ΄λ“λ΅μ½”ν‹°μ† μ™Έμ©μ μ™€ λ³‘μ©(ν•¨κ» λ³µμ©(μ‚¬μ©))μ— μ‚¬μ©ν•©λ‹λ‹¤.

### π•’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - μ©λ²• λ° μ©λ‰
* μ„±μΈ λ° 6μ„Έ μ΄μƒμ μ†μ•„λ” μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—ΌμΌλ΅μ¨ 1μΌ 1νΒ 10 mgμ„Β μ·¨μΉ¨ μ „μ— κ²½κµ¬ ν¬μ—¬(λ³µμ©)ν•μ‹­μ‹μ¤.

μ΄μƒλ°μ‘μ— λ―Όκ°ν• ν™μμ κ²½μ°λ” 5 mgμ”©μ„ μ•„μΉ¨, μ €λ…μ— λ¶„ν•  λ³µμ©ν•©λ‹λ‹¤.

μ—°λ Ή, μ¦μƒμ— λ”°λΌ μ μ ν μ¦κ°ν•μ‹­μ‹μ¤.

μ‹ μ¥μ• (μ‹ μ¥(μ½©ν¥)μ¥μ• ) ν™μλ” ν™μμ μ‹ (μ½©ν¥)κΈ°λ¥μ— λ”°λΌ ν¬μ—¬ κ°„κ²© λ° μ©λ‰μ„ μ΅°μ ν•΄μ•Ό ν•©λ‹λ‹¤. μμ„Έν• μ‚¬ν•­μ€ ν—κ°€μ‚¬ν•­μ„ μ°Έκ³ ν•μ‹­μ‹μ¤.

### β οΈ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - μ£Όμμ‚¬ν•­
* μ •λ³΄ μ—†μ
* μ΄ μ•½μ— κ³Όλ―Όμ¦ ν™μ λλ” κ²½ν—μ, μ‹ (μ½©ν¥)λ¶€μ „ ν™μ(ν¬λ μ•„ν‹°λ‹ μ²­μ†μ¨ 

μ΄ μ•½μ„ λ³µμ©ν•κΈ° μ „μ— μ‹ μ¥μ• (μ‹ μ¥(μ½©ν¥)μ¥μ• ), κ°„μ¥μ•  ν™μ, λ…ΈμΈ, λ‡μ „μ¦ ν™μ λ° λ°μ‘ μ„ν—μ„±μ΄ μλ” ν™μ, μ†λ³€κ³ μ„μ μ„ ν–‰μ”μΈ(μ²™μ λ³‘λ³€(λ³‘μ— μν• λΈμ λ³€ν™”), μ „λ¦½μ„ (μ „λ¦½μƒ) λΉ„λ€μ¦)μ΄ μλ” ν™μ, μ„λ¶€, μμ λ¶€λ” μμ‚¬ λλ” μ•½μ‚¬μ™€ μƒμν•μ‹­μ‹μ¤.

μ•λ λ¥΄κΈ° ν•­μ›ν”Όλ‚΄λ°μ‘κ²€μ‚¬λ¥Ό λ°›λ” ν™μμ κ²½μ°Β κ²€μ‚¬ μ‹¤μ‹ 3~5μΌ μ „μ—λ” μ΄ μ•½μ„ λ³µμ©ν•μ§€ λ§μ‹­μ‹μ¤.

#EN
### π’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - Efficacy and Indications
* This medicine is used for seasonal and perennial allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria (of unknown cause), pruritus (skin itching), eczema, and dermatitis (in combination with topical hydrocortisone).

### π•’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - Dosage and Administration
* Adults and children 6 years of age and older should orally administer 10 mg of cetirizine hydrochloride once daily, before bedtime.

For patients sensitive to adverse reactions, 5 mg should be taken in divided doses in the morning and evening.

Adjust the dose appropriately depending on age and symptoms.

Patients with renal impairment should adjust the dosing interval and dose according to their renal function. Refer to the full prescribing information for details.

### β οΈ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - Precautions
* Patients with hypersensitivity to this drug or a history thereof, patients with renal failure (creatinine clearance [The original text ends here; please refer to the complete information.])
* Before taking this medicine, patients with renal impairment, hepatic impairment, the elderly, patients with epilepsy and those at risk of seizures, patients with predisposing factors for urinary retention (e.g., spinal cord lesion, prostatic hypertrophy), pregnant women, and lactating women should consult a doctor or pharmacist.
* Patients undergoing allergy skin tests should not take this medicine 3 to 5 days prior to the test.

---

#CN
### π’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - εζ•δΈι€‚εΊ”η—‡
* ζ¬θ―η”¨δΊε­£θ‚ζ€§εεΈΈεΉ΄ζ€§θΏ‡ζ•ζ€§ιΌ»η‚γ€θΏ‡ζ•ζ€§η»“θ†η‚γ€ζ…Άζ€§η‰Ήε‘ζ€§οΌεε› δΈζη„οΌ‰θ¨ιΊ»η–Ήγ€η®θ‚¤η™η—’η—‡γ€ζΉΏη–Ήγ€η®η‚οΌδΈε¤–η”¨ζ°Άε–ε―η„ζΎεΉ¶η”¨οΌ‰γ€‚

### π•’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - η”¨ζ³•η”¨ι‡
* ζδΊΊε6ε²δ»¥δΈε„Ώη«¥οΌζ―ζ—¥δΈ€ζ¬΅οΌη΅ε‰ε£ζη›ι…Έθ¥Ώζ›Ώε©ε—10ζ―«ε…‹γ€‚

ε―ΉδΈθ‰―εεΊ”ζ•ζ„η„ζ‚£θ€…οΌε―ε°†5ζ―«ε…‹ε‰‚ι‡ε†ζ—©ζ™ζη”¨γ€‚

θ―·ζ Ήζ®εΉ΄ιΎ„ε’η—‡η¶ι€‚ε½“εΆε‡ε‰‚ι‡γ€‚

θ‚Ύεθƒ½δΈε…¨ζ‚£θ€…εΊ”ζ Ήζ®ε…¶θ‚Ύεθƒ½θ°ƒζ•΄η»™θ―ι—΄ι”ε’ε‰‚ι‡γ€‚θ―¦ζƒ…θ―·ε‚θ€ƒθ―ε“θ―΄ζδΉ¦γ€‚

### β οΈ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ζ³¨ζ„δΊ‹ι΅Ή
* ε―Ήζ¬θ―θΏ‡ζ•ζ–ζ‰θΏ‡ζ•ε²η„ζ‚£θ€…οΌθ‚Ύεθƒ½θ΅°η«­ζ‚£θ€…οΌθ‚ι…ζΈ…ι™¤η‡ [εζ–‡θ‡³ζ­¤η»“ζοΌθ―·ε‚θ€ƒε®ζ•΄δΏ΅ζ―γ€‚]οΌ‰
* ζη”¨ζ¬θ―ε‰οΌθ‚Ύεθƒ½δΈε…¨ζ‚£θ€…γ€θ‚εθƒ½δΈε…¨ζ‚£θ€…γ€θ€εΉ΄δΊΊγ€η™«η—«ζ‚£θ€…εζ‰η™«η—«ε‘δ½ι£ι™©η„ζ‚£θ€…γ€ζ‰ε°Ώζ½΄η•™θ―±ε› οΌε¦‚θ„ι«“η—…εγ€ε‰ε—θ…Ίθ‚¥ε¤§οΌ‰η„ζ‚£θ€…γ€ε­•ε¦‡γ€ε“ΊδΉ³ζε¦‡ε¥³εΊ”ε’¨θ―Άε»η”ζ–θ―εΈγ€‚
* ζ¥ε—θΏ‡ζ•εη®ε†…εεΊ”θ―•ιη„ζ‚£θ€…οΌθ―·ε¨θ―•ιε‰3θ‡³5ε¤©εζ­Άζη”¨ζ¬θ―γ€‚

---

#JP
### π’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - εΉθƒ½γƒ»εΉζ
* γ“γ®θ–¬γ―γ€ε­£η―€ζ€§εγ³ι€εΉ΄ζ€§γ‚Άγƒ¬γƒ«γ‚®γƒΌζ€§ιΌ»η‚γ€γ‚Άγƒ¬γƒ«γ‚®γƒΌζ€§ηµθ†η‚γ€ζ…Άζ€§η‰Ήη™Ίζ€§οΌεε› δΈζγ®οΌ‰θ•ιΊ»η–Ήγ€η®θ†γγ†η—’η—‡γ€ζΉΏη–Ήγ€η®θ†η‚οΌγƒ’γƒ‰γƒ­γ‚³γƒ«γƒγ‚Ύγƒ³ε¤–η”¨ε‰¤γ¨γ®δ½µη”¨οΌ‰γ«η”¨γ„γ‚‰γ‚γΎγ™γ€‚

### π•’ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - η”¨ζ³•γƒ»η”¨ι‡
* ζδΊΊεγ³6ζ­³δ»¥δΈγ®ε°ε…γ―γ€γ‚»γƒγƒγ‚Έγƒ³ε΅©ι…Έε΅©γ¨γ—γ¦1ζ—¥1ε›10 mgγ‚’ε°±ε―ε‰γ«ηµε£ζ•δΈγ—γ¦γγ γ•γ„γ€‚

ε‰―δ½η”¨γ«ζ•ζ„γζ‚£θ€…γ®ε ΄εγ―γ€5 mgγγ¤γ‚’ζγ€ε¤•γ«ε†ε‰²ζη”¨γ—γΎγ™γ€‚

εΉ΄ι½Άγ€η—‡η¶γ«εΏγγ¦ι©ε®εΆ—ζΈ›γ—γ¦γγ γ•γ„γ€‚

θ…ζ©θƒ½ιε®³ζ‚£θ€…γ―γ€ζ‚£θ€…γ®θ…ζ©θƒ½γ«εΏγγ¦ζ•δΈι–“ι”εγ³η”¨ι‡γ‚’θΏη―€γ™γ‚‹εΏ…θ¦γγ‚γ‚γΎγ™γ€‚θ©³η΄°γ«γ¤γ„γ¦γ―γ€ζ·»δ»ζ–‡ζ›Έγ‚’γ”ε‚η…§γγ γ•γ„γ€‚

### β οΈ μ ν•μ„Έν‹°λ¦¬μ§„μ •(μ„Έν‹°λ¦¬μ§„μ—Όμ‚°μ—Ό) - ζ³¨ζ„δΊ‹ι …
* ζ¬ε‰¤γ«ε―Ύγ—ιζ•η—‡γ®γ‚γ‚‹ζ‚£θ€…γΎγγ―ζ—ΆεΎ€ζ­΄γ®γ‚γ‚‹ζ‚£θ€…γ€θ…δΈε…¨ζ‚£θ€…οΌγ‚―γƒ¬γ‚Άγƒγƒ‹γƒ³γ‚―γƒγ‚Άγƒ©γƒ³γ‚Ή [εζ–‡γ―γ“γ“γ§ι€”ε‡γ‚γ¦γ„γΎγ™γ€‚ε®ε…¨γζƒ…ε ±γ«γ¤γ„γ¦γ―γ€ζ·»δ»ζ–‡ζ›Έγ‚’ε‚η…§γ—γ¦γγ γ•γ„γ€‚]οΌ‰
* ζ¬ε‰¤γ‚’ζη”¨γ™γ‚‹ε‰γ«γ€θ…ζ©θƒ½ιε®³γ€θ‚ζ©θƒ½ιε®³ζ‚£θ€…γ€ι«ι½Άθ€…γ€γ¦γ‚“γ‹γ‚“ζ‚£θ€…εγ³η™Ίδ½γ®γƒγ‚Ήγ‚―γ®γ‚γ‚‹ζ‚£θ€…γ€ε°Ώθ²―η•™γ®ε…θ΅θ¦ε› οΌθ„ι«„η—…ε¤‰γ€ε‰η«‹θ…Ίθ‚¥ε¤§η—‡οΌ‰γγ‚γ‚‹ζ‚£θ€…γ€ε¦ε©¦γ€ζδΉ³ε©¦γ―ε»εΈ«γΎγγ―θ–¬ε‰¤εΈ«γ«γ”η›Έθ«‡γγ γ•γ„γ€‚
* γ‚Άγƒ¬γƒ«γ‚®γƒΌζ—εη®ε†…εεΏζ¤ζ»γ‚’ε—γ‘γ‚‹ζ‚£θ€…γ®ε ΄εγ€ζ¤ζ»ε®ζ–½3ο½5ζ—¥ε‰γ«γ―ζ¬ε‰¤γ‚’ζη”¨γ—γγ„γ§γγ γ•γ„γ€‚